Contract award · W81XWH19C0193
CREATION OF AN FDA APPROVED ANALGESIC KETAMINE DRUG WITH AUTO INJECTOR DELIVERY SYSTEM.
Awarded to EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. · CAGE 057Y1
Latest reported total obligated
Not reported
Net observed obligations
$5.7M
Observed contract actions
14
Observed period
FY2019–FY2024
Reported totals are cumulative values from the latest available award record. Observed obligations and actions reflect Mimir's FY2019 onward transaction window and may omit earlier activity.
Award parties and scope
ContractorEMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.
CAGE057Y1
CustomerDepartment of the Army
Performance locationGAITHERSBURG, MARYLAND, UNITED STATES
Procurement details
First observed actionSep 26, 2019
Latest observed actionJul 17, 2024
PSCAN93
NAICS541715 · Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CompetitionFULL AND OPEN COMPETITION
PricingCOST PLUS FIXED FEE
SolicitationW81XWH19R0032
Annual observed obligations
FY2019
$5.7M
FY2021
$5.4M
FY2023
-$4.2M
FY2024
-$1.1M
Continue exploring
Ask Mimir about W81XWH19C0193
Continue with this contract award already in context.
ContinueExplore the full award in Mimir
Open the complete action history and connected analysis in the platform.